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Abstract: 
 
The effect of acute (24‐h) sleep deprivation on exercise‐induced growth hormone (GH) and 
insulin‐like growth factor‐1 (IGF‐1) was examined. Ten men (20.6 ± 1.4 years) completed two 
randomized 24‐h sessions including a brief, high‐intensity exercise bout following either a night 
of sleep (SLEEP) or (24‐h) sleep deprivation (SLD). Anaerobic performance (mean power [MP], 
peak power [PP], minimum power [MinP], time to peak power [TTPP], fatigue index, [FI]) and 
total work per sprint [TWPS]) was determined from four maximal 30‐sec Wingate sprints on a 
cycle ergometer. Self‐reported sleep 7 days prior to each session was similar between SLEEP 
and SLD sessions (7.92 ± 0.33 vs. 7.98 ± 0.39 h, P = 0.656, respectively) and during the actual 
SLEEP session in the lab, the total amount of sleep was similar to the 7 days leading up to the 
lab session (7.72 ± 0.14 h vs. 7.92 ± 0.33 h, respectively) (P = 0.166). No differences existed in 
MP, PP, MinP, TTPP, FI, TWPS, resting GH concentrations, time to reach exercise‐induced 
peak GH concentration (TTP), or free IGF‐1 between sessions. GH area under the curve (AUC) 
(825.0 ± 199.8 vs. 2212.9 ± 441.9 μg/L*min, P < 0.01), exercise‐induced peak GH concentration 
(17.8 ± 3.7 vs. 39.6 ± 7.1 μg/L, P < 0.01) and ΔGH (peak GH – resting GH) (17.2 ± 3.7 vs. 38.2 
± 7.3 μg/L, P < 0.01) were significantly lower during the SLEEP versus SLD session. Our results 
indicate that the exercise‐induced GH response was significantly augmented in sleep‐deprived 
individuals. 
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Abstract
The effect of acute (24-h) sleep deprivation on exercise-induced growth hor-
mone (GH) and insulin-like growth factor-1 (IGF-1) was examined. Ten men
(20.6  1.4 years) completed two randomized 24-h sessions including a brief,
high-intensity exercise bout following either a night of sleep (SLEEP) or (24-
h) sleep deprivation (SLD). Anaerobic performance (mean power [MP], peak
power [PP], minimum power [MinP], time to peak power [TTPP], fatigue
index, [FI]) and total work per sprint [TWPS]) was determined from four
maximal 30-sec Wingate sprints on a cycle ergometer. Self-reported sleep
7 days prior to each session was similar between SLEEP and SLD sessions
(7.92  0.33 vs. 7.98  0.39 h, P = 0.656, respectively) and during the actual
SLEEP session in the lab, the total amount of sleep was similar to the 7 days
leading up to the lab session (7.72  0.14 h vs. 7.92  0.33 h, respectively)
(P = 0.166). No differences existed in MP, PP, MinP, TTPP, FI, TWPS, rest-
ing GH concentrations, time to reach exercise-induced peak GH concentration
(TTP), or free IGF-1 between sessions. GH area under the curve (AUC)
(825.0  199.8 vs. 2212.9  441.9 lg/L*min, P < 0.01), exercise-induced
peak GH concentration (17.8  3.7 vs. 39.6  7.1 lg/L, P < 0.01) and DGH
(peak GH – resting GH) (17.2  3.7 vs. 38.2  7.3 lg/L, P < 0.01) were sig-
nificantly lower during the SLEEP versus SLD session. Our results indicate
that the exercise-induced GH response was significantly augmented in sleep-
deprived individuals.
Introduction
Human growth hormone (GH) is secreted from the ante-
rior pituitary gland, which is heavily regulated by growth
hormone-releasing hormone (GHRH) and somatostatin
(SMS). In addition, GH output is mediated by ghrelin
(GHS) and insulin-like growth factor-1 (IGF-1). GH is
secreted in a pulsatile fashion, with the strongest physio-
logic stimuli being sleep and exercise.
Humans spend approximately one-third of their lives
sleeping (Morris et al. 2012). The major secretory GH
pulse occurs just after sleep onset and continues to rise
during the first 4 h. Most GH release occurs during non-
rapid-eye movement (NREM) sleep within the slow-wave
sleep (SWS) phase with little GH secreted during rapid-
eye movement (REM) sleep (Takahashi et al. 1968; Parker
et al. 1969; Sassin et al. 1969; Holl et al. 1991; Van Cau-
ter et al. 1992a,b). Individuals undergoing some form of
sleep deprivation, such as doctors, nurses, shift workers
and military personnel, offer many of our important soci-
etal services. Additionally, athletes and coaches believe
that sleep is essential for peak physical performance.
There are many situations where sleep is disturbed prior
to an athletic event including travel, changes in time
zones and anxiety. Exponentially, student-athletes in
higher education are forced to accommodate their study
schedule for athletic events, resulting in altered sleep hab-
its and/or sleep loss in order to study for exams. In these
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situations, the question arises as to how exercise may be
used to neutralize the physiological effects of sleep depri-
vation in regard to GH.
Sleep deprivation can alter hypothalamus and pituitary
function, which de-synchronizes GH release timing (Van
Cauter et al. 1992a; Wiebel et al. 1997; Brun et al. 1998;
Brandenberger and Wiebel 2004; Everson and Crowley
2004). During complete sleep deprivation of 24–36 h, GH
release is attenuated and in some cases, absent (Takahashi
et al. 1968; Sassin et al. 1969; Karacan et al. 1971; Brun
et al. 1998; Brandenberger and Wiebel 2004). Brun et al.
(1998) reported that GH release was dramatically reduced
during a 36-h sleep-deprived session with the most notice-
able decrease in nocturnal GH peak values (28.2  17.9
µg/L vs. 5.5  3.4 µg/L, for control and sleep deprivation
sessions, respectively). Peak nocturnal GH secretory bursts
were observed in the subjects between 23:00 and 2:30 h
during the control session. During the sleep-deprived ses-
sion, the nocturnal peak amplitude and total GH area
under the curve (AUC) were dramatically reduced
although the total number of GH peaks during the 24-h
sampling period was similar between the control and
sleep-deprived session. Futhermore, Brandenberger et al.
(2000) reported that 24-h GH pulsatility profiles were dif-
ferent between habitual sleepers and adapted night shift
workers. Not only was nocturnal GH release lower in
adapted night shift workers, but 24-h GH pulsatility was
more frequent, sporadic and unpredictable throughout
waking hours. Based on these observations, we assume that
complete sleep deprivation can attenuate the GH response
the morning after and this is likely the result of of the dis-
turbance of the sleep-wake cycle.
Exercise is a proven stimulus of GH release and an
acute bout of exercise stimulates a significant GH pulse
(Sutton and Lazarus 1976; Bunt et al. 1986; Felsing et al.
1992; Weltman et al. 1992, 2006; Chwalbinska-Moneta
et al. 1996; Pritzlaff et al. 1999, 2000; Wideman et al.
1999, 2000a,b, 2002; Pritzlaff-Roy et al. 2002; Godfrey
et al. 2003). Although there is large interindividual varia-
tion in exercise-induced GH release, it is a reproducible
measure within subjects (Stokes et al. 2003; Makimura
et al. 2008). Multiple studies have shown that shorter
bouts of high-intensity exercise can elicit an elevated
growth hormone response (Nevill et al. 1996; Kanaley
et al. 1997; Stokes et al. 2002a,b, 2004, 2005). Peak GH
release occurs within ~30–45 min after the initiation of
sprint exercise and a single 6-sec sprint can augment GH
release (Stokes et al. 2002a), although a slightly longer
30-sec sprint enhances GH release further (Nevill et al.
1996; Stokes et al. 2002b, 2005).
To our knowledge, no one has examined the effects of
acute (24-h) sleep deprivation on exercise-induced GH
release using short-term, high-intensity exercise. The two
studies that have examined the effects of exercise-induced
GH release during complete (24-h) sleep deprivation and
exercise-induced GH release during partial sleep depriva-
tion have yielded inconsistent results largely due to meth-
odological differences involving protocols that only
partially disturbed the sleep-wake cycle (Mougin et al.
2001; Abedelmalek et al. 2013). Considering GH release
begins around the onset of sleep, partial sleep deprivation
may still provide sufficient rest to elicit a normal noctur-
nal GH release and thus, limit the alterations observed in
subsequent exercise-induced GH release. Therefore, the
purpose of this study was to investigate the effects of
acute sleep deprivation on subsequent exercise-induced
GH release. Since we anticipated that GH production and
storage would continue during a period of sleep depriva-
tion followed by a subsequent bolus of release upon stim-
ulation, we hypothesized that GH release will be
augmented in response to short-term, high-intensity exer-
cise following a 24-h period of continuous sleep depriva-
tion.
Methods
Subject characteristics
Ten men (9 Caucasians and 1 African-American), ages
18–22 years (20.6  1.4 years) with a mean body mass
index of 26.6  2.5 kg/m2, and body fat percentage of
20.9  6.8%, completed the study. On average, subjects
reported participating in high-intensity activity 1 day per
week and spent 4–6 h per week participating in recrea-
tional physical activity and reported minimal occupa-
tional physical work. All subjects provided written
informed consent in accordance with the institutional
review board at the University of North Carolina at
Greensboro and Winston-Salem State University. All sub-
jects underwent a strict preliminary screening session
prior to inclusion. Subjects were excluded if they: (1) had
a body fat percentage >30%, (2) reported a history of
hematological, renal, hepatic, metabolic or thyroid dys-
function, (3) were currently on a caloric restriction pro-
gram (diet) or taking any medications that promoted
weight loss, (4) currently smoked or had quit smoking
within the previous 3 months, (5) had documented sleep
disturbances or irregular sleeping patterns such as night
shift work or recreational habits, (6) had completed trans-
meridian travel within the last month, or (7) participated
in greater than 10 hours of recreational activities (swim-
ming, basketball, jogging, cycling etc.) per week or were
involved in any type of sprint training within the last
6 months. Self-reported sleep logs were kept for seven
days prior to both 24-h laboratory sessions. Epworth
Sleepiness scales were used to screen for baseline excessive
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subjective sleepiness and/or irregular sleeping habits
(Johns 1991).
Individuals who met the inclusion criteria completed a
brief familiarization session on an electronically braked
cycle ergometer (Lode Excalibur Sport, Lode BV, Gronig-
nen, The Netherlands). Equipment used to collect meta-
bolic measures using standard open circuit spirometry
(TrueOne metabolic measurement system from Parvo-
Medics [(Sandy, UT)] during exercise was fitted during
this familiarization session, but no gases were collected.
Experimental design
Subjects completed one baseline 24-h laboratory session
where their acute exercise response was measured follow-
ing a night of sufficient rest and compared to the identi-
cal exercise-induced response following a 24-h sleep
deprivation session (Fig. 1). Subjects were instructed to
refrain from exercise 48 h prior to their randomized labo-
ratory session. In order to control for order effects, a
counterbalanced design was used in which half the sub-
jects performed the sleep deprivation session (SLD) first
and the other half performed the control sleep session
(SLEEP) first. Testing days of the week were standardized
within subjects and separated by 3 weeks. For both ses-
sions, subjects reported to the Exercise Physiology labora-
tory at 0800 h. Ambient light and temperature in the
laboratory were held constant between 0800 and 2200 h.
During the SLEEP session, subjects were allowed adequate
rest in a light-controlled environment (2200–0600 h) and
investigators only entered the room briefly (<5 min) to
check on the subject. If a subject was unable to remain
asleep the entire period, they were asked to remain in bed
in darkness until an investigator beckoned them at
0600 h. During the SLD session, subjects were sleep-
deprived by only allowing them to rest in wakeful state or
pursue intellectual activities between the hours of 2200 to
0600 h. They were kept sedentary throughout the session,
but were allowed to read, study and watch movies, and
researchers maintained social interaction with the subjects
throughout the entire sleep-deprived session. During this
time, the ambient light in the laboratory was unchanged
from daylight hours.
Body composition measurements
During the first randomized laboratory session, subjects
had their body composition assessed via whole body dual-
energy X-ray absorptiometry (DXA) scan (Lunar-Prodigy
Advance Plus, GE) at 0900 h. All scans were performed in
fan beam mode using the thick scan mode (recommended
by GE for research purposes; scan time was approximately
20 min). Fat mass (FM) and fat-free mass (FFM) were
measured for the whole body and regional areas.
Standardized caloric intake
A detailed dietary log was recorded for each subject 72 h
prior to and through the conclusion of each session and
then analyzed for total calories using myfitnesspal.com.
No caffeine or alcohol was allowed for the 48 h preceding
laboratory studies through the completion of the 24-h
Figure 1. Experimental protocol showing the 24-h laboratory sessions. The design was counter-balanced and randomized between sessions.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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session. Daily caloric intake was standardized during each
session for all subjects based on their estimated basal met-
abolic rate using the Harris Benedict Principle (Harris
and Benedict 1918) (BMR = [66.4730 + 13.7516 9 weight
{kg}] + [5.0033 9 height {cm}][6.7550 9 age {years}] *
[physical activity]). Each subject was instructed to eat
within ~600 kcal of their predetermined daily caloric
intake each time they came to the laboratory and to stay
consistent with their meals during each subsequent
session. At 2000 h, subjects were given a standardized
~600 kcal snack that had a macronutrient content of
~45% carbohydrate, ~20% protein and ~35% fat. Follow-
ing their snack, subjects fasted throughout the remainder
of their session (2000–0900 h).
Exercise testing protocol
Upon catheter insertion at 0600 h, subjects rested pas-
sively in a chair while flow meters and gas analyzers were
calibrated for collection of metabolic measurements using
open circuit spirometery [(TrueOne metabolic measure-
ment system from ParvoMedics (Sandy, UT). After
20 min of passive rest, subjects were fitted with their
headgear and mouth pieces to breath through to initiate
gas collection while they continued to rest for another
25 min to insure accurate resting metabolic rate (RMR)
data collection postcatheter insertion. Forty-five minutes
into their passive rest period subjects, completed a 5-min
standardized submaximal warm-up that consisted of ped-
aling on a cycle ergometer at: 60 watts (W) for 4 min,
80 W for 30 sec and 100 W for 30 sec. At 0700 h, sub-
jects completed four maximal 30-sec sprints on a cycle
ergometer against an electronically applied resistance
equivalent to 7.5% of their body weight (kg). Each sprint
was followed by 4 min of active recovery on the cycle
ergometer at 50 W.
Blood sampling and analysis
Blood was collected by a trained technician through a cath-
eter inserted into an arm vein in the antecubital space.
Catheter patency was maintained by displacing the blood
in the catheter with isotonic saline at regular intervals. A
heating pad was placed over the antecubital area in order
to minimize peripheral venoconstriction and maximize
patency during the postexercise period. Blood samples
were taken at seventeen different time points (Fig. 2) and,
on average, every 15 min (~Q15) for 180 min, with more
frequent sampling just prior to initiating the first exercise
sprint and immediately after the 4th exercise sprint a post-
exercise blood sample was collected. Blood samples were
allowed to clot at room temperature for 30 min. Samples
were then centrifuged at 3000 rpm for 15 min at 4°C.
Serum was extracted and pipetted into microcentrifuge
tubes and stored at 80°C until subsequently analyzed.
Growth hormone from all time points were determined
in duplicate using a human GH enzyme-linked immuno-
sorbant assay (MP Biomedicals, Solon, OH). The mini-
mum detectable dose of this assay was 0.5 lg/L and the
intra-assay variance was 2.2–2.9%. Insulin-like growth
factor-1 (IGF-1) immediate preexercise and 120 min
postexercise onset (~106 min postexercise) was assayed in
duplicate using an in vitro enzyme-linked immunosorbent
assay (Raybiotech, Norcross, GA). The minimum detect-
able dose of this assay was 0.1 lg/L and the intra-assay
variance was <10%. To eliminate interassay variance, all
samples from a single subject were assayed within the
same plate.
Figure 2. Blood draw profile. Samples were collected over 3-h that included ~30 min of resting metabolic rate (RMR) data collection and
blood draws that occur every 15 min on average, with more frequent sampling around the 13-min exercise session. BD, blood draw. There
were 17 blood draws in total.
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Statistical analysis
Sleep (self-reported average amount of sleep per night)
patterns prior to and during each session were examined
using a paired-sample t-test. Fifteen second breath-
by-breath averages of oxygen consumption (VO2), carbon
dioxide (VCO2), metabolic equivalents (METS), respira-
tory rate (RR), ventilation (VE), tidal volume (VT) and
respiratory exchange ratio (RER) were calculated from
open circuit spirometery for 30 min prior to exercise
through the end of exercise (Q-30 to Q15; 0630 h–
0715 h). A paired-sample t-test was used to determine
whether there were any differences in physiological data
during rest and exercise values between the SLD and
SLEEP sessions. When data was non-normally distributed,
a nonparametric Wilcoxin test for two related samples
was used to adjust for the skewedness.
Analysis of anaerobic performance data was done in a
stepwise fashion. First, mean power (MP), peak power
(PP), minimum power (MinP), time to peak power
(TTPP), fatigue index (FI), and total work completed
(TW) were calculated from each of the sprint exercise tests.
Data descriptives were then examined for violations of test
assumptions (skewedness) and those variables that were
non-normally distributed were examined using the non-
parametric Wilcoxin test for 2 related samples in a preli-
minary analysis of each sprint between sessions (sprint 1
SLD vs. sprint 1 SLEEP). Then, a two-way analysis of vari-
ance with repeated measures was used to determine if dif-
ferences in performance existed between the SLD and
SLEEP sessions (main effect – session) and between the
average sprint performance score in each session (main
effect – sprint). When the assumption of sphericity was
violated, the Greenhouse-Geisser correction was used.
Mean GH area under the curve (AUC) was calculated
using the trapezoidal integration method. Data from each
time point was included in the calculation. The AUC was
calculated as previously described in detail (Stokes et al.
2003). Briefly, the intersection where the GH concentra-
tions and time points created an ordinate was joined to
form a straight line that created a trapezium. The area of
each trapezium was calculated using the equation:
area = (y1 + y2) 9 0.5 9 d, where y1 + y2 are the GH
concentrations at two successive time points and d is the
time interval between the two samples. Peak values refer to
the mean of the highest measured concentrations for each
individual. Resting GH was determined by the mean of the
initial three time points (60, 45, 30) preceding the
exercise warm-up. A repeated measures ANOVA, with
Greenhouse-Geisser correction, was conducted to assess
whether there were differences between the average exer-
cise-induced GH concentration between the SLEEP and
SLD sessions (main effect of session) and the response of
each subject with respect to the 13 time points when blood
draws occurred, starting at 0700 h just prior to exercise
onset (main effect of time). Whenever mean differences
were observed, mean comparisons were examined using a
Wilcoxon signed-rank test with appropriate Bonferroni
corrections. Test-retest (Pearson) correlations were used to
indicate the rank order of peak GH concentration and GH
AUC within and between subjects. Repeated measures
ANOVA was also used to determine any differences in free
IGF-1 and lactate before and after exercise. The level of
statistical significance was set at P < 0.05. All statistical
analyses were performed using PASW for Windows, ver-
sion 22.0 (Chicago, IL). All results are expressed as means
 SEM, unless otherwise noted.
Results
Sleep
All subjects self-reported normal routines of work and
sleep and had experienced no transmeridian travel within
the last three months. Subjects did not experience sleep
deprivation and demonstrated a normal sleep pattern over
the previous 7 days as per their self-reported sleep recall
logs. The average amount of self-reported sleep in the
7 days prior to each session was similar between the
SLEEP and SLD sessions (7.92  0.33 vs. 7.98  0.39 h,
P = 0.656, respectively). During the SLEEP session in the
lab, subjects reported that they slept an average of
7.72  0.14 h, which was similar to the 7 days leading
up to the lab session (7.92  0.33 h) (P = 0.166) Mean
Epworth Sleepiness Scale scores were 6.4  1.6, which
was within the normal range (Johns 1991).
Exercise performance
Anaerobic performance (average of all 4 sprints) did not
differ between sessions (Table 1). Additionally, VCO2,
RER, RR, exercise VO2, peak VO2, METS, VE and VT
data were all non-normally distributed and therefore,
nonparametric Wilcoxon tests for two related samples
were ran to correct for the skewed data. Similar to anaer-
obic performance, none of the cardiorespiratory response
to exercise values was significantly different between
sessions (Table 2).
Growth hormone
GH AUC (exercise + recovery), peak GH concentration
and DGH were significantly lower during the SLEEP
session (P < 0.01) whereas resting GH release and time to
reach peak GH concentration did not differ between
sessions (Table 3). Results of the repeated measures
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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ANOVA indicated a significant interaction effect between
time point and session, F (1.957, 35.221) = 4.434,
P < 0.05, g2 = 0.198. There were also significant main
effects for time point, F (1.957, 35.221) = 25.450,
P < 0.01, g2 = 0.586, and session, F (1, 18) = 7.858,
P < 0.05, g2 = 0.304. Figure 3 shows the mean GH con-
centrations during exercise + recovery, starting at exercise
onset (0700 h, i.e., time point 0), that included four suc-
cessive 30 s maximal sprints with 4 min of active recovery
on a cycle ergometer. Wilcoxon signed-rank tests were
used to further examine which average GH concentrations
(by time point) differed between sessions. Results indi-
cated that exercise-induced GH concentrations were sig-
nificantly lower during the SLEEP session compared to
the SLD session from the onset of exercise (time point 0)
through the remainder of the 120-min profile.
Individual GH AUC and peak GH concentrations
increased significantly in all subjects even though there
was a large degree of interindividual variation during
both sessions. However, subjects stayed within the same
approximate rank response order during both sessions
and this was confirmed by the statistically significant test-
retest correlations between sessions for both GH AUC
(r = 0.888, P < 0.01) and peak GH concentration (r =
0.845, P < 0.05).
Free IGF-1
A repeated measures ANOVA indicated that free IGF-1
was similar following exercise, F (1, 12) = 0.945,
P = 0.350, g2 = 0.073, and was also similar between ses-
sions, F (1, 12) = 0.871, P = 0.429, g2 = 0.053. Further-
more, there was no interaction effect of exercise and
session, F (1, 18) = 0.228, P = 0.642, g2 = 0.019 (Fig. 4).
Lactate
Exercise significantly increased blood lactate concentra-
tions over resting values during both SLD (M  SEM)
(1.49  0.14 vs. 15.79  1.40 mmol/L, P < 0.01) and
SLEEP sessions (1.54  0.19 vs. 17.15  1.54 mmol/L,
P < 0.01). However, no differences in blood lactate con-
centrations existed between SLD and SLEEP sessions at
rest (1.49  0.14 vs. 1.54  0.19 mmol/L, P = 0.811)
Table 1. Anaerobic performance (M  SD).
Variable SLEEP SLD P
Mean power (W) 528  69 515  75 0.175
Peak power (W) 1131  198 1118  183 0.681
Minimum power (W) 271  69 272  71 0.940
Time to peak
power (sec)
1.1  0.4 0.9  0.2 0.135
Fatigue Index (%) 29.8  5.9 29.1  5.9 0.546
Total work (W) 15,850  2067 15,441  2264 0.175
Average sprint performance values across all sprints during the
sleep (SLEEP) and sleep deprivation (SLD) sessions. P values were
adjusted for skewedness (>1.0) of the non-normally distributed data
using the nonparametric Wilcoxin test for two related samples.
Table 2. Cardiorespiratory response to exercise (M  SD).
Variable SLEEP SLD P Adjusted P†
VO2 (L/min)
1 2.04  0.43 2.04  0.42 0.986 0.906
VO2
(mL/kg/min) 1
23.4  4.1 23.4  3.9 0.973 0.878
METS1 6.7  1.2 6.7  1.1 0.936 0.959
VCO2 (L/min)
1 2.48  0.35 2.98  1.14 0.181 0.415
Ventilation
(VE) L/min1
90.6  26.7 80.4  19.3 0.209 0.139
(RER)1 1.4  0.4 1.5  0.5 0.724 0.374
(RR) brths/min1 33.3  5.3 31.1  6.9 0.260 –
Tidal Volume
(VT) L/min1
2.59  0.68 2.53  0.58 0.672 0.443
VO2 peak
(L/min)
3.36  0.59 3.52  0.66 0.388 –
VO2peak
(mL/kg/min)
38.3  4.7 39.9  4.7 0.434 –
METSmax 11.0  1.4 11.4  1.3 0.436 –
RR, respiratory rate; RER, respiratory exchange ratio.
Exercise cardiorespiratory data by session.
1Average values over ~15 min of exercisedata collection.
†P values were adjusted for skewedness (>1.0) of non-normally
distributed data using the nonparametric Wilcoxin ranked signs
test for two related samples.
Table 3. Growth hormone concentrations (M  SEM).
Variable SLEEP SLD P Adjusted P†
Resting
GH (lg/L)
0.57  0.13 1.35  0.55 0.181 0.575
Peak
GH (lg/L)
17.8  3.7 39.6  7.1 0.002*
Time to
Peak
GH (min)
29.5  2.2 27.0  1.5 0.299 0.257
DGH (lg/L) 17.2  3.7 38.2  7.3 0.003*
GH AUC
(lg/L/min)1
825.0  199.8 2212.8  441.9 0.001*
1GH AUC during exercise and recovery only.
*P < 0.01.
†When data was non-normally distributed, P values were adjusted
for skewedness (>1.0) using the nonparametric Wilcoxon sign-
ranked test.
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and immediately following exercise (15.79  1.40 vs.
17.15  1.54 mmol/L, P = 0.467). The univariate analysis
of variance revealed no interaction effect of exercise and
session on blood lactate concentrations (P = 0.533).
Discussion
The primary findings from the current study can be sum-
marized as follows 1) early morning resting GH concen-
tration was unaffected by sleep deprivation, and 2)
exercise-induced GH AUC (168%), peak GH concentra-
tion (123%) and D GH (122%) were significantly greater
following a night of sleep deprivation.
The present study supports previous research that sug-
gests short-term, high-intensity exercise augments the GH
response following a night of adequate sleep (Nevill et al.
1996; Kanaley et al. 1997; Stokes et al. 2002a,b, 2003,
2004, 2005; Stokes 2003) and partial sleep deprivation
(Abedelmalek et al. 2013). It has been proposed that
intense physical activity combined with caloric and sleep
restriction can amplify GH secretion (Nindl et al. 2003).
However, few studies have attempted to examine the sin-
gular effects of acute sleep deprivation on exercise-
induced GH release. Abedelmalek et al. (2013) reported
that growth hormone was increased following partial sleep
deprivation using repeated brief sprint exercises similar to
the current study. In Abedelmalek et al. (2013), thirty
healthy, college-aged athletes exercised at 0800 h after
only being allowed to sleep from 2230 to 0300 h com-
pared to our complete lack of overnight sleep during the
SLD session. During each of their exercise sessions, sub-
jects completed 4 x 250-m runs on a treadmill at a con-
stant intensity of 80% of an individualized maximal speed
with 3-min recovery intervals. However, Abedelmalek
et al. (2013) failed to report significant elevations in GH
immediately postexercise due to lack of postexercise fol-
lowup time points and the fact that the exercise-induced
Figure 3. Mean GH concentrations at each time point between SLEEP and SLD sessions during exercise and recovery. *Results indicated a
significant interaction effect between time point and session (P < 0.05), and main effects for time point (P < 0.01) and session (P < 0.05).
†Wilcoxon signed-rank tests indicated that exercise-induced GH concentrations were significantly lower at each timepoint during the SLEEP
session from the onset of exercise (time point 0) through the remainder of the 120-min profile. Total GH AUC was significantly greater during
the SLD versus SLEEP session (P < 0.01).
Figure 4. Free IGF-1 response pre- and 90 min postexercise
between sessions.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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GH response was much less than the current study. These
differences are likely due to the partial and not complete
(24-h) sleep deprivation utilized by Abedelmalek et al.
(2013) and its subsequent effects on nocturnal GH release
and feedback mechanisms. For example, Mougin et al.
(2001) reported that partial sleep deprivation did not
affect exercise-induced GH release. However, in this
study, subjects were awoken as soon as they were about
to enter rapid-eye movement (REM) sleep unlike Abedel-
malek et al. (2013) that allowed subjects to sleep for 4
consecutive hours. They were kept awake by pursuing
sedentary activities in bed for 3 h before being allowed
back to sleep until 0700 h and remained sedentary until
their exercise session at 0200 h. Within a normal episode
of sleep, the first four stages constitute NREM) sleep and
are made up of several cycling stages of consciousness
and slow-wave brain activity. Typically, most GH release
occurs during this NREM phase constituting slow-wave
sleep (SWS) that occurs within these first 4 h (Takahashi
et al. 1968; Parker et al. 1969; Sassin et al. 1969; Karacan
et al. 1971; Van Cauter et al. 1992a,b) with little GH
secreted during subsequent REM sleep (Holl et al. 1991).
Thus, subjects in the Mougin et al. (2001) and Abedel-
malek et al. (2013) studies were not sleep deprived during
the SWS phase when most nocturnal GH release occurs
and this is likely the reason why exercise-induced GH
release was similar in both admissions. This is in agree-
ment with a much earlier study by Karacan et al. (1971),
who reported lower GH concentrations during sleep
deprivation in which subjects were awakened prior to
entering SWS. Based on these previous observations
examining exercise-induced GH release during partial
sleep deprivation, we believe the current investigation is
the first to report the response of growth hormone to
short-term, high-intensity exercise following acute (24-h)
sleep deprivation.
Total GH AUC and peak GH concentration during the
SLEEP condition were similar to previously reported
research (Stokes et al. 2002a,b, 2003, 2004, 2005, 2010;
Stokes 2003) but during the SLD session they were
increased 2.7-fold and 2.2-fold, respectively. Our subjects
were not sprint-trained and had exercise-induced peak GH
concentrations during SLEEP that were similar to endur-
ance trained males during a 30-sec treadmill sprint (17.8
vs. 15.9 lg/L, respectively). However, when the same sub-
jects were sleep deprived, their exercise-induced peak GH
concentration were only slightly lower than the maximal
peak GH values recorded in sprint-trained males (39.6 vs.
44.0 lg/L, respectively) (Nevill et al. 1996). This suggests
that the capacity for GH synthesis and storage in sprint-
trained individuals may be augmented in a manner that is
similar to what is observed during acute SLD and when a
sprint exercise stimulus is provided, the magnitude of the
GH response is similar regardless of training status.
However, the mechanisms regulating GH synthesis and
storage in these two scenarios (sprint-trained vs. sleep
deprived) are likely to be different and are yet to be fully
elucidated.
Despite these large differences between the SLEEP and
SLD conditions, there was still a large interindividual var-
iation in GH concentration and peak GH. Test–retest
(Pearson) correlations of GH AUC and peak GH concen-
tration between sessions in the current study were similar
to those that were reported by Stokes et al. (2003) (rang-
ing from r = 0.89 to 0.97, P < 0.05). Stokes et al. (2003)
reported significant test–retest correlations when subjects
performed one 30-s all-out sprint followed by 60 min of
recovery on two separate occasions, separated by 7 days.
However, our test–retest correlations were similar across
two separate conditions (SLEEP vs. SLD). This likely rep-
resents the rank response order within subjects (i.e., those
that a large GH response during the SLEEP session also
had a large, yet amplified GH response during the SLD
session). Therefore, the slightly lower test–retest correla-
tions in our study depict the augmented GH response
related to sleep deprivation.
In the current study, peak power was greater in the
first sprint of the SLEEP versus SLD session; although the
overall mean across all four sprints was similar between
sessions. However, it is unlikely that the minor difference
in exercise performance between the sessions allowed a
signficant contribution of feedback to the neuroendocrine
system (i.e., somatotropic axis) from the localized muscle
activation. This is strengthened by the fact that the time
to reach the peak GH concentration did not differ
between sessions and was similar to previous reports
using high-intensity sprint exercise (Stokes et al. 2002b,
2003, 2005). This suggests that the neuroendocrine
response related to the onset of exercise appears unaf-
fected by sleep deprivation. Likely the large, acute stress
of high-intensity exercise on the neuroendocrine system
was sufficient to override any lingering effects that sleep
deprivation had on the system’s regulation.
During exercise recovery, GH typically returns to base-
line within 2 h regardless of aerobic or high-intensity
exercise (Wideman et al. 1999, 2000a,b; Pritzlaff-Roy
et al. 2002; Stokes et al. 2002a; Weltman et al. 2006).
Data from exercise recovery during the current study sug-
gests that the neuroendocrine systems related to recovery
were also unaltered during sleep deprivation. In the cur-
rent study, GH concentrations were significantly elevated
compared to rest for 60-min postexercise in both sessions
(Fig. 3) and this is similar to the previously mentioned
study using short-term, high-intensity exercise (Abedel-
malek et al. 2013). Since we cannot conclude that short-
term, high intensity exercise during sleep deprivation
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results in greater exercise-induced GH recovery time
beyond the expected postexercise period (i.e., 60-min), we
can suggest that (1) the half-life of GH is unaffected by
sleep deprivation and (2) the increase in GH AUC is a
result of a greater total GH output over the same time
frame.
Few studies have evaluated the effects of brief sprint
interval exercise on IGF-1; however, Meckel et al. (2009)
reported that GH concentrations increased with no subse-
quent change in IGF-1 up to 1 h postexercise after sub-
jects completed 4 successive sprints similar to the current
study. In addition, IGF-1 has been shown to be unaf-
fected during 3 nights of subsequent delta-wave sleep
interruption (Older et al. 1998), however partial sleep
deprivation has been shown to decrease total IGF-1 con-
centrations only when combined with severe energy defi-
cit caused by caloric deprivation and arduous physical
activity (Alemany et al. 2008). In the current study, we
controlled dietary intake so that it was standardized
within subjects and between sessions with a focus on
avoiding caloric restriction, which may explain why free
IGF-1 was unaffected in the current study. While IGF-1 is
known to exert a negative long-loop, multilevel feedback
effect on GH release (Le Roith et al. 2001), free IGF-1
values were not influenced by exercise or sleep depriva-
tion in the current study and therefore, this long-loop,
multilevel feedback was likely not a primary contributor
to the enchanced GH response observed during SLD.
More research needs to be conducted on the primary
effects of exercise during sleep deprivation on GH-medi-
ated IGF-1 without the confounding effects of caloric
restriction and negative energy balance.
Our results demonstrate that short-term, high-intensity
exercise is a very strenuous stimulus capable of enhancing
GH release with or without sleep deprivation. While noc-
turnal GH release was not assessed in the current study,
we assume that nocturnal GH release was minimal during
sleep deprivation. Results support our hypothesis that
short-term high-intensity exercise appears to override the
sleep deprivation-induced mechanisms that blunt GH
release, resulting in a maximal GH response when exercise
follows sleep deprivation. Metabolic effects of GH may
potentially augment glucose availability for priority tis-
sues, such as neuronal activity in the brain, during stress-
ful states such as sleep deprivation, caloric restriction, and
negative energy balance. Additionally, the ability of sleep
deprivation to alter the exercise-induced GH pulsatility
profile could have substantial downstream GH-mediated
biological effects during the days following these types of
events. When the innate sleep schedule is disrupted, 24-h
GH pulsatility is more sporadic and frequent “bursts” of
GH released throughout a 24-h period transpires to make
up for the significantly lower and unassociated GH pulse
that occurs at sleep onset (Brandenberger and Wiebel
2004). GH regulates fat metabolism, which influences
body composition and insulin sensitivity. It has been
demonstrated that lipolysis is upregulated in the presence
of larger intermittent but not smaller continuous GH
infusion (Laursen et al. 2001). If in fact exercise during
sleep deprivation does normalize GH pulsatility patterns,
then humans with disrupted sleep schedules may benefit
metabolically by exercising following sleep deprivation,
creating a more uniform intermittent pulse of GH release
versus a more sporadic 24-h GH release pattern. These
substantial downstream GH-mediated biological effects
could lead to improvement in body composition, glucose
tolerance or even muscle growth and repair for sleep-
deprived individuals (i.e., students, athletes, doctors,
nurses, parents of newborns).
In conclusion, we have demonstrated that exercise can
override the attenuation of the GH release during sleep
deprivation to elicit a maximal GH response greater than
exercise following a night of adequate sleep. Future
research should examine the interaction between exercise
and GH release mediators during sleep deprivation as well
as the capability of exercise to normalize 24-h GH pulsa-
tility (and subsequent metabolic consequences) when nor-
mal sleep schedules are disrupted. Additionally, little is
known about the effects of the exercise-induced GH
response during sleep deprivation and whether or not it
“hyper-activates” an auto-negative feedback mechanism
to suppress its own release throughout the day, so that
total 24-h GH AUC is similar to that of a 24-h sleep-
deprived session without exercise.
Conflict of interest
Ritsche K, Nindl BC and Wideman, L have nothing to
declare.
References
Abedelmalek, S., N. Souissi, H. Chtourou, M. Denquezli,
C. Aouichaoui, M. Ajina, et al. 2013. Effects of partial sleep
deprivation on proinflammatory cytokines, growth
hormone, and steroid hormone concentrations during
repeated brief sprint interval exercise. Chronobiol. Int.
30:502–509.
Alemany, J. A., B. C. Nindl, M. D. Kellogg, W. J. Tharion,
A. J. Young, and S. J. Montain. 2008. Effects of
dietary protein content on IGF-1, testosterone, and body
composition during 8 days of severe energy deficit and
arduous physical activity. J. Appl. Physiol. 105:58–64.
Brandenberger, G., and L. Wiebel. 2004. The 24-h growth
hormone rhythm in men: sleep and circadian influences
questioned. J. Sleep Res. 13:251–255.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 10 | e12166
Page 9
K. Ritsche et al. Sleep Deprivation/Exercise Growth Hormone
Brandenberger, G., C. Gronfier, F. Chapotot, C. Simon, and F.
Piquard. 2000. Effect of sleep deprivation on overall 24 h
growth-hormone secretion (Abstract). Lancet 356:1408.
Brun, J., G. Chamba, Y. Khalfallah, P. Girard, I. Boissy, H.
Bastuji, et al. 1998. Effect of modafinil on plasma
melatonin, cortisol and growth hormone rhythms, rectal
temperature and performance in healthy subjects during a
36 h sleep deprivation. J. Sleep Res. 7:105–114.
Bunt, J. C., R. A. Boileau, J. M. Bahr, and R. J. Nelson. 1986.
Sex and training differences in human growth hormone
during prolonged exercise. J. Appl. Physiol. 61:1796–1801.
Chwalbinska-Moneta, J., F. Krysztofiak, A. Ziemba, K. Nazar,
and H. Kaciuba-Uscilko. 1996. Threshold increases in
plasma growth hormone in relation to plasma
catecholamine and blood lactate concentration during
progressive exercise in endurance-trained athletes. Eur.
J. Appl. Physiol. Occup. Physiol. 73:117–120.
Everson, C. A., and W. R. Crowley. 2004. Reductions in
circulating anabolic hormones induced by sustained sleep
deprivation rats. Am. J. Physiol. Endocrinol. Metab. 286:
E1060–E1070.
Felsing, N. E., J. A. Brasel, and D. M. Cooper. 1992. Effect of
low and high intensity exercise on circulating growth
hormone in men. J. Clin. Endocrinol. Metab. 75:157–162.
Godfrey, R. J., Z. Madgwick, and G. Whyte. 2003. The
exercise-induced growth hormone response in athletes.
Sports Med. 33:599–613.
Harris, J. A., and F. G. Benedict. 1918. A biometric study of
human basal metabolism. Proceed. Natl Acad. Sci. USA
4:370–373.
Holl, R. W., M. L. Hartman, J. D. Veldhuis, W. M. Taylor,
and M. O. Thorner. 1991. Thirty-second sampling of plasma
growth hormone in man: correlation with sleep stages.
J. Clin. Endocrinol. Metab. 72:854–861.
Johns, M. W. 1991. A new method for measuring daytime
sleepiness: the Epworth Sleepiness Scale. Sleep 14:540–545.
Kanaley, J. A., J. Y. Weltman, J. D. Veldhuis, A. D. Rogol, M.
L. Hartman, and A. Weltman. 1997. Human growth
hormone response to repeated bouts of aerobic exercise.
J. Appl. Physiol. 83:1756–1761.
Karacan, I., A. L. Rosenbloom, R. L. Williams, W. W. Finley,
and C. J. Hursch. 1971. Slow wave sleep deprviation in
relation to plasma growth hormone concentration. Behav.
Neuropsychiatry 2:11–14.
Laursen, T., C. H. Gravholt, L. Heickendorff, J. Drustrup,
A. M. Kappelgaard, J. O. Jorgenson, et al. 2001. Long-term
effects of continuous infusion vs. daily subcutaneous
injections of growth hormone (GH) on insulin-like growth
factor system, insulin sensitivity, body composition, and
bone and lipoprotein metabolism in GH-deficient adults.
J. Clin. Endocrinol. Metab. 86:1222–1228.
Le Roith, D., L. Scavo, and A. Butler. 2001. What is the role of
circulating IGF-I? Trends Endocrinol. Metab. 12:48–52.
Makimura, H., T. Stanley, D. Mun, S. M. You, and S.
Grinspoon. 2008. The effects of central adiposity on growth
hormone (GH) response to GH-releasing hormone-arginine
stimulation testing in men. J. Clin. Endocrinol. Metab.
93:4254–4260.
Meckel, Y., A. Eliakim, M. Seraev, F. Zaldivar, D. M. Cooper,
M. Sagiv, et al. 2009. The effect of a brief sprint interval
exercise on growth factors and inflammatory mediators.
J. Strength Cond. Res. 23:225–230.
Morris, C. J., D. Aeschbach, and F. A. Scheer. 2012. Circadian
system, sleep and endocrinology. Mol. Cell. Endocrinol.
349:91–104.
Mougin, F., H. Bourdin, M.L. Simon-Rigaud, U. Nguyen Nhu,
J.P. Kantelip, and D. Davenne. 2001. Hormonal responses to
exercise after partial sleep deprivation and after hypnotic
drug-induced sleep. J. Sports Sci. 19:89–97.
Nevill, M. E., D. J. Holmyard, G. M. Hall, P. Allsop, A. van
Oosterhout, J. M. Burrin, et al. 1996. Growth hormone
responses to treadmill sprinting in sprint-and
endurance-trained athletes. Eur. J. Appl. Physiol. 72:
460–467.
Nindl, B. C., J. W. Castellani, A. J. Young, J. F. Patton,
M. J. Khosravi, A. Diamandi, et al. 2003. Differential
responses of IGF-1 molecular complexes to military
operational field training. J. Appl. Physiol. 95:1083–1089.
Older, S. A., D. F. Battafarano, C. L. Danning, J. A. Ward,
E. P. Grady, S. Derman, et al. 1998. The effects of delta
wave sleep interruption on pain thresholds and
fibromyalgia-like symptoms in healthy subjects;
correlations with insulin-like growth factor I. J.
Rheumatol. 25:1180–1186.
Parker, D. C., J. F. Sassin, J. W. Mace, R. W. Gotlin, and
L. G. Rossman. 1969. Human growth hormone release
during sleep: electroencephalographic correlation. J. Clin.
Endocrinol. Metab. 29:871–874.
Pritzlaff, C. J., L. Wideman, Y. J. Weltman, R. D. Abbott,
M. E. Gutgesell, M. L. Hartman, et al. 1999. Impact of acute
exercise intensity on pulsatile growth hormone release in
men. J. Appl. Physiol. 87:498–504.
Pritzlaff, C. J., L. Wideman, J. Blumer, M. Jensen,
R. D. Abbott, G. A. Gaesser, et al. 2000. Catecholamine
release, growth hormone secretion, and energy expenditure
during exercise vs. recovery in men. J. Appl. Physiol.
89:937–946.
Pritzlaff-Roy, C. J., L. Wideman, J. Y. Weltman, R. Abbott,
M. Gutgesell, M. L. Hartman, et al. 2002. Gender governs
the relationship between exercise intensity and growth
hormone release in young adults. J. Appl. Physiol.
92:2053–2060.
Sassin, J. F., D. C. Parker, J. W. Mace, R. W. Gotlin,
L. C. Johnson, and L. G. Rossman. 1969. Human growth
hormone release: relation to slow-wave sleep and
sleep-walking cycles. Science 165:513–515.
2014 | Vol. 2 | Iss. 10 | e12166
Page 10
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Sleep Deprivation/Exercise Growth Hormone K. Ritsche et al.
Stokes, K. A. 2003. Growth hormone responses to
sub-maximal and sprint exercise. Growth Horm. IGF Res.
13:225–238.
Stokes, K. A., M. E. Nevill, G. M. Hall, and H. K. A. Lakomy.
2002a. Growth hormone responses to repeated maximal
cycle ergometer exercise at different pedaling rates. J. Appl.
Physiol. 92:602–608.
Stokes, K. A., M. E. Nevill, G. M. Hall, and H. K. A. Lakomy.
2002b. The time course of the human growth hormone
response to a 6 s and a 30 s cycle ergometer sprint. J. Sport
Sci. 20:487–494.
Stokes, K. A., M. E. Nevill, H. K. Lakomy, and G. M. Hall.
2003. Reproducibility of the growth hormone response to
sprint exercise. Growth Horm. IGF Res. 13:336–340.
Stokes, K. A., M. E. Nevill, P. W. Cherry, H. K. Lakomy, and
G. M. Hall. 2004. Effect of 6 weeks of sprint training on
growth hormone responses to sprinting. Eur. J. Appl.
Physiol. 92:26–32.
Stokes, K. A., M. E. Nevill, J. Frystyk, H. Lakomy, and
G. M. Hall. 2005. Human growth hormone responses to
repeated bouts of sprint exercise with different
recovery periods between bouts. J. Appl. Physiol. 99:
1254–1261.
Stokes, K. A., D. Sykes, K. L. Gilbert, J. W. Chen, and J.
Frystyk. 2010. Brief, high intensity exercise alters serum
ghrelin and growth hormone concentrations but not IGF-I,
IGF0-II or IGF-1 bioactivity. Growth Horm. IGFI Res.
20:289–294.
Sutton, J., and L. Lazarus. 1976. Growth hormone in exercise:
comparison of physiological and pharmacological stimuli.
J. Appl. Physiol. 41:523–527.
Takahashi, Y., D. M. Kipnis, and W. H. Daughaday. 1968.
Growth hormone secretion during sleep. J. Clin. Invest.
47:2079–2090.
Van Cauter, E., A. Caufriez, M. Kerkhofs, A. Van Onderbergen,
M. O. Thorner, and G. Copinschi. 1992a. Sleep, awakenings,
and insulin-like growth factor-I modulate the growth
hormone (GH) secretory response to GH-releasing hormone.
J. Clin. Endocrinol. Metab. 74:1451–1459.
Van Cauter, E., M. Kerkhofs, A. Caufriez, A. Van
Onderbergen, M. O. Thorner, and G. Copinschi. 1992b.
A quantitative estimation of growth hormone secretion in
normal man: reproducibility and relation to sleep and time
of day. J. Clin. Endocrinol. Metab. 74:1441–1450.
Weltman, A., J. Weltman, R. Schurrer, W. S. Evans,
J. D. Veldhuis, and A. D. Rogol. 1992. Endurance training
amplifies the pulsatile release of growth hormone: effects of
training intensity. J. Appl. Physiol. 76:2188–2196.
Weltman, A., J. Weltman, C. P. Roy, L. Wideman, J. Patrie,
W. S. Evans, et al. 2006. Growth hormone response to
graded exercise intensities is attenuated and the gender
difference abolished in older adults. J. Appl. Physiol.
100:1623–1629.
Wideman, L., J. Weltman, N. Shah, S. Story, J. D. Veldhuis,
and A. Weltman. 1999. Effects of gender on
exercise-induced growth hormone release. J. Appl. Physiol.
87:1154–1162.
Wideman, L., J. Weltman, J. T. Patrie, C. Y. Bowers, N. Shah,
S. Story, et al. 2000a. Synergy of L-arginine and GHRP-2
stimulation of GH in men and women: modulation by
exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 217:
R1467–R1477.
Wideman, L., J. Weltman, J. Patrie, C. Y. Bowers, N. Shah,
S. Story, et al. 2000b. Synergy of L-arginine and growth
hormone (GH)-releasing peptide-2 on GH release: influence
of gender. Am. J. Physiol. Regulatory Integrative Comp.
Physiol. 279:R1455–R1466.
Wideman, L., J. Y. Weltman, M. L. Hartman, J. D. Veldhuis,
and A. Weltman. 2002. Growth hormone release during
acute and chronic aerobic and resistance exercise: recent
findings. Sports Med. 32:987–1004.
Wiebel, L., M. Follenius, K. Spiegel, C. Gronfier, and
G. Brandenberger. 1997. Growth hormone secretion in night
workers. Chronobiol. Int. 14:49–60.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 10 | e12166
Page 11
K. Ritsche et al. Sleep Deprivation/Exercise Growth Hormone
